Shire’s New Drugs Defence to AbbVie - Presented by: The Aol. On Network

The fight back is on - the pharmaceutical group Shire is adopting tried and tested tactics to fend off AbbVie. The US firm is offering $46 billion for the British company. Shire says it's not enough and has a promising range of drugs to prove it. It says its current products will generate sales of at least $7 billion by 2020 with $3bln coming from drugs in the pipeline. It's also a serial acquirer - and has benefitted from six deals in the past 13 months.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 114.64 3.80 ▼ 3.21%
BAX $ 40.31 0.80 ▲ 2.02%
S $ 3.49 0.15 ▲ 4.49%
BAC $ 17.80 0.03 ▲ 0.17%
BXLT $ 37.10 3.95 ▲ 11.92%
MGM $ 21.75 1.90 ▲ 9.57%
FTR $ 5.25 0.10 ▲ 1.94%
MSFT $ 47.54 0.73 ▲ 1.56%

As of 8/4/2015, 04:15 PM

Latest News Headlines

View All Latest Headlines